Management Policy
Directors（As of June 23, 2026）
Directors
Ryuji Katsura, President and Representative Director
Biography / Reason for Appointment
| April 1988 | Joined the Company |
|---|---|
| July 2007 | General Manager of Finance Department |
| July 2010 | General Manager of Corporate Planning Department |
| July 2011 | Executive Officer |
| June 2013 | Director in charge of corporate planning |
| April 2017 | Head of Corporate Planning Division |
| July 2019 | Head of Global Marketing Division |
| April 2021 | Head of Corporate Affairs Division |
| June 2021 | Executive Director |
| June 2023 | President and Representative Director(present) |
<Reason for appointment>
Mr. Ryuji Katsura has abundant work experience in planning, finance and international business at the Company. Since June 2023, as President and Representative Director, he has been directing the Company's overall management and business operations, thereby contributing to enhancement of the Company's corporate value. We believe he will continue to leverage his experience and knowledge to demonstrate leadership, facilitate strategic and agile decision-making of the Board of Directors and further promote the growth of the JMS Group.
Yasuhiro Awane, Vice President and Director
Head of Sales and Marketing Division
Biography / Reason for Appointment
| April 1984 | Joined the Company |
|---|---|
| April 2010 | Head of Sales Promotion Division |
| June 2011 | Director, Sales and Marketing Division |
| June 2013 | Director in charge of sales and marketing |
| June 2015 | Executive Director |
| April 2017 | Head of Surgical & Therapeutical Business Unit , Head of Sales and Marketing Division(present) |
| June 2021 | Senior Executive Director |
| June 2023 | Vice President and Director(present) |
| July 2023 | Head of Corporate Strategy Office |
<Reason for appointment>
Mr. Yasuhiro Awane has abundant work experience in sales and planning divisions at the Company, as well as deep knowledge in the marketing field. Since June 2011, he has been involved in the management of the Company as a Director while leading the sales division, and since June 2023, as Vice President, he has been contributing to enhancement of the Company's corporate value. We believe he will continue to leverage his experience and knowledge to demonstrate leadership, facilitate strategic and agile decision-making of the Board of Directors and further promote the growth of the JMS Group.
Shogo Yanagida, Executive Director
Head of Production Division
Biography / Reason for Appointment
| April 1986 | Joined the Company |
|---|---|
| April 2003 | Manager of Research Section 2-2, Central Research Laboratory |
| April 2010 | General Manager of First Manufacturing Department, Izumo Plant |
| November 2011 | General Manager of Technology Development Department, Izumo Plant |
| July 2013 | Executive Officer, Miyoshi Plant Manager |
| June 2017 | Director, Deputy Head of Production Division |
| June 2019 | Head of Production Division(present) |
| April 2020 | Head of Blood Management & Cell Therapy Business Unit |
| June 2023 | Izumo Plant Manager |
| June 2026 | Executive Director(present) |
<Reason for appointment>
Mr. Shogo Yanagida has abundant work experience in production and research & development divisions at the Company. Since June 2017, he has been involved in the management of the Company as a Director while leading the production division, thereby contributing to enhancement of the Company's corporate value. We believe he will continue to leverage his experience and knowledge to facilitate strategic and agile decision-making of the Board of Directors and further promote the growth of the JMS Group.
Tohru Sakoda, Director
Head of Global Marketing Division
Biography / Reason for Appointment
| April 1989 | Joined the Company |
|---|---|
| April 2002 | Section Chief, Technology Section, Chiyoda Plant |
| April 2004 | Manager of Regulatory Affairs Office, Regulatory Affairs & Quality Assurance Department |
| April 2012 | Manager of Research Section 3 |
| July 2017 | Executive Officer, General Manager of Cardiovascular Products, Surgical & Therapeutical Business Unit |
| July 2019 | President and Representative Director, JMS Singapore PTE.LTD. |
| June 2023 | Director(present), Head of Global Marketing Division(present) |
<Reason for appointment>
Mr. Tohru Sakoda has extensive work experience in production, research & development, and regulatory affairs & quality assurance divisions at the Company, as well as in the management of overseas subsidiaries. Since June 2023, he has been involved in the management of the Company as a Director while leading the international business division, thereby contributing to enhancement of the Company's corporate value. We believe he will continue to leverage his experience and knowledge to facilitate strategic and agile decision-making of the Board of Directors and further promote the growth of the JMS Group.
Raita Uematsu, Director
Head of Research and Development Division
Biography / Reason for Appointment
| October 2001 | Joined the Company |
|---|---|
| July 2005 | Manager of Research Section 1-1, Central Research Laboratory |
| July 2013 | General Manager of Technology Development Department, Izumo Plant |
| June 2018 | Deputy Plant Manager, Izumo Plant |
| July 2019 | Executive Officer, Plant Manager of Izumo Plant |
| June 2023 | Director(present), Head of Research and Development Division(present) |
<Reason for appointment>
Mr. Raita Uematsu has abundant work experience in research & development and production divisions at the Company. Since June 2023, he has been involved in the management of the Company as a Director while leading the research & development division, thereby contributing to enhancement of the Company's corporate value. We believe he will continue to leverage his experience and knowledge to facilitate strategic and agile decision-making of the Board of Directors and further promote the growth of the JMS Group.
Shozo Ishizaka, Director(Outside)
Biography / Reason for Appointment
| April 1985 | Joined Kaneka Corporation |
|---|---|
| June 2010 | Director, Head of Vascular Management Group, Sales Management Department, and Head of Asia Office of Kaneka Medix Corporation |
| April 2017 | Vice President of Kaneka Medix Corporation |
| April 2018 | President of Kaneka Medix Corporation |
| June 2019 | Director of the Company(present) |
| April 2023 | Executive Officer of Kaneka Corporation(present) |
<Reason for appointment>
Mr. Shozo Ishizaka has extensive track record and knowledge in the medical device industry at Kaneka Corporation and Kaneka Medix Corporation, and has been appropriately supervising the Company's management as an Outside Director. We highly value his experience and capabilities, and believe he will continue to play a sufficient role in making decisions on management matters and supervising business execution of the JMS Group.
Nobuhiko Watabe, Director(Outside)
Biography / Reason for Appointment
| March 1982 | Joined Mazda Motor Corporation |
|---|---|
| February 2002 | Deputy General Manager, Corporate Planning Division, Mazda Motor Corporation |
| April 2006 | Deputy General Manager, Domestic Marketing Division, Mazda Motor Corporation |
| January 2011 | General Manager, China Business Division, Mazda Motor Corporation |
| June 2013 | Executive Officer in charge of China Business and General Manager, China Business Division, Mazda Motor Corporation; Executive President, Mazda(China) Enterprise Management Co., Ltd. |
| April 2016 | Executive Officer in charge of China Business, Mazda Motor Corporation; Chairman, Mazda(China) Enterprise Management Co., Ltd. |
| April 2017 | Managing Executive Officer in charge of China Business, Mazda Motor Corporation; Chairman, Mazda(China) Enterprise Management Co., Ltd. |
| April 2021 | Managing Executive Officer, Assistant to Global Sales, Mazda Motor Corporation |
| June 2021 | Director and Full-time Audit and Supervisory Committee Member, Mazda Motor Corporation |
| June 2025 | Retired as Director and Full-time Audit and Supervisory Committee Member, Mazda Motor Corporation |
| June 2026 | Director of the Company(present) |
<Reason for appointment>
Mr. Nobuhiko Watabe has held important positions at Mazda Motor Corporation, and has abundant domestic and international work experience and extensive knowledge particularly in corporate planning, domestic marketing and China business areas. We highly value his knowledge and track record, and believe he will play a sufficient role in making decisions on management matters and supervising business execution of the JMS Group from an independent standpoint.
Yoshio Kondo, Director
Full-Time Audit & Supervisory Committee Member
Biography / Reason for Appointment
| April 1980 | Joined the Company |
|---|---|
| July 2005 | Head of International Business Division |
| July 2011 | President and Representative Director, JMS SINGAPORE PTE. LTD. |
| June 2015 | General Manager of Finance Department |
| June 2018 | Standing Audit & Supervisory Board Member |
| June 2023 | Director(present), Full-Time Audit & Supervisory Committee Member(present) |
<Reason for appointment>
Mr. Yoshio Kondo has abundant work experience in Administration at the Company. In addition, he has served as President of our overseas subsidiary. In view of the transition to a company with Audit and Supervisory Committee, we believe he will contribute strengthening of audits and supervision of the business execution of the JMS Group with his specialized experience and knowledge he has gained through his career.
Akira Mito, Director(Outside)
Audit & Supervisory Committee Member
Biography / Reason for Appointment
| July 2013 | Resigned from District Director of Okayama West Tax Office |
|---|---|
| August 2013 | Established Mito Tax Accountant Office(present) |
| June 2015 | Substitute Audit & Supervisory Board Member of the Company |
| June 2016 | Audit & Supervisory Board Member of the Company |
| June 2023 | Director of the Company(present), Audit & Supervisory Committee Member(present) |
<Reason for appointment>
Mr. Akira Mito has abundant professional knowledge and experience as a tax accountant, and has performed his duties as an outside auditor appropriately. In view of the transition to a company with Audit and Supervisory Committee, we believe he will contribute strengthening of audits and supervision of the business execution of the JMS Group with his specialized experience and knowledge he has gained through his career.
Yoshiharu Sagami, Director(Outside)
Audit & Supervisory Committee Member
Biography / Reason for Appointment
| April 1981 | Joined Asahi & Co.(present KPMG AZSA LLC) |
|---|---|
| June 2010 | Resigned from KPMG AZSA LLC |
| July 2010 | Established Sagami CPA Office(present) |
| June 2015 | Outside Director and Audit Committee Member of Br. Holdings Corporation(present) |
| June 2020 | Audit & Supervisory Board Member of the Company |
| June 2023 | Director of the Company(present), Audit & Supervisory Committee Member(present) |
<Reason for appointment>
Mr. Yoshiharu Sagami has abundant professional knowledge and experience as a certified public accountant, and has performed his duties as an outside auditor appropriately. In addition, he has served as an outside director, audit and supervisory committee member of other company. In view of the transition to a company with Audit and Supervisory Committee, we believe he will contribute strengthening of audits and supervision of the business execution of the JMS Group with his specialized experience and knowledge he has gained through his career.